Merck has pulled the plug on not one but two coronavirus vaccines in clinical trials. Here’s my report: https://t.co/RnctVxN2He We’re up to three abandoned vaccines on the @nytimes tracker https://t.co/v45MRgj80t
6
140
245
Replies
@carlzimmer @nytimes We should get Merck manufacturing capacity utilized to make other vaccines
0
0
3
@carlzimmer @GlennKesslerWP @nytimes Could companies with failed attempts at new vaccines just give up and turn to manufacturing the successful vaccines? We’ve already found good vaccines.
0
0
2
@carlzimmer @nytimes Hi Carl, two questions if you could kindly answer - the vaccines that uses inactivated or attenuated coronavirus will generally perform poorly to these new variants, right? And how about mRNA vs Viral Vector (Adeno virus based) performing generally to these new variants?
1
0
0
@carlzimmer @edrybicki @nytimes Will they return 35 million USD public funding, got per default like every pharma?
0
0
0